Form 4 for STX Seagate Technology
Accepted 2025-05-30 00:00:00 ET · period of report 2025-05-29 · accession 0001137789-25-000094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-30 | 2025-05-30 | STX | Romano Gianluca | EVP, CFO | M - OptEx | $87.34 | +26.8K | 64.9K | +70% | +$2.34M |
| DM | 2025-05-30 | 2025-05-29+ | STX | Romano Gianluca | EVP, CFO | S - Sale+OE | $117.45 | -51.8K | 47.2K | -52% | -$6.09M |
| D | 2025-05-30 | 2025-05-30 | STX | Romano Gianluca | EVP, CFO | M - OptEx | $0.00 | -26.8K | 5,364 | -83% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-05-30 | M | A | 26,816 | $87.34 | 64,898 | D | — | — | (F4) The option exercise and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 27, 2025. |
| 2 | Common | Ordinary Shares | 2025-05-29 | S | D | 9,100 | $117.56 | 38,082 | D | — | — | (F1) These Ordinary Shares were sold under a Rule 10b5-1 trading plan adopted by the Reporting Person on January 27, 2025. (F3) These Ordinary Shares were sold in multiple trades at prices ranging from $117.45 to $117.92. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Ordinary Shares | 2025-05-30 | S | D | 15,631 | $117.38 | 49,267 | D | — | — | (F4) The option exercise and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 27, 2025. (F5) These Ordinary Shares were sold in multiple trades at prices ranging from $116.67 to $117.65. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Ordinary Shares | 2025-05-30 | S | D | 11,185 | $117.86 | 38,082 | D | — | — | (F4) The option exercise and sales of Ordinary Shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 27, 2025. (F6) These Ordinary Shares were sold in multiple trades at prices ranging from $117.67 to $118.24. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Ordinary Shares | 2025-05-29 | S | D | 15,918 | $117.17 | 47,182 | D | — | — | (F1) These Ordinary Shares were sold under a Rule 10b5-1 trading plan adopted by the Reporting Person on January 27, 2025. (F2) These Ordinary Shares were sold in multiple trades at prices ranging from $116.43 to $117.41. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Derivative | NQ Options | 2025-05-30 | M | D | 26,816 | $0.00 | 5,364 | D | $87.34 · — to 2028-09-09 | 26,816 Ordinary Shares | (F7) Options granted to the Reporting Person under the Plan are subject to a four-year vesting schedule. Subject to the Reporting Person's continuous employment, one-quarter of the options will vest on September 9, 2022 and the remaining options vest in equal monthly installments over the 36 months following September 9, 2022. |